6 research outputs found
DAAHCVGNTablesIFNmodified – Supplemental material for Immunosuppressive and antiviral treatment of hepatitis C virus–associated glomerular disease: A long-term follow-up
<p>Supplemental material, DAAHCVGNTablesIFNmodified for Immunosuppressive and antiviral treatment of hepatitis C virus–associated glomerular disease: A long-term follow-up by Fabrizio Fabrizi, Alessio Aghemo, Pietro Lampertico, Mirella Fraquelli, Donata Cresseri, Gabriella Moroni, Patrizia Passerini, Francesca M Donato, Piergiorgio Messa in The International Journal of Artificial Organs</p
Carriage rate frequencies (%) of VEGF 936 C/T in patients with <sup>*</sup>IRF and <sup>**</sup>IAAA, and VEGF I/D in patients with/without ureteral obstruction, conservative treatment, and deep vein thrombosis<sup>&</sup>.
*<p>Idiopathic retroperitoneal fibrosis (IRF);</p>**<p>inflammatory abdominal aortic aneurysms (IAAA);</p>&<p>Values are the number/total number examined (%).</p><p>OR = odds ratio; 95% CI = 95% confidence intervals.</p
Alleles, genotypes and carriage rate frequencies (%) of the Toll-like receptor (TLR) 4 polymorphism Asp299Gly in patients with chronic periaortitis and control subjects<sup>*</sup>.
*<p>Values are the number/total number examined (%).</p><p>OR = odds ratio; 95% CI = 95% confidence interval.</p
Serum VEGF levels in 17 patients with chronic periaortitis (CP) and 11 age- and gender-matched healthy controls (HC).
<p><b>VEGF tended to be higher in the CP group, but the difference was not statistically significant (p = 0.081).</b></p
Alleles, genotypes and carriage rates frequencies (%) of VEGF I/D, 936 C/T, 634 C/G in patients and control subjects<sup>*</sup>.
*<p>Values are the number/total number examined (%).</p><p>OR = odds ratio; 95% CI = 95% confidence intervals.</p
Demographic and clinical characteristics of the 102 patients with chronic periaortitis<sup>*</sup><sup>&</sup>.
*<p>Values indicate the percentage of patients unless otherwise indicated.</p>&<p>Some characteristics were not available for all 102 patients.</p>**<p>Atherosclerotic disease: the presence of coronary artery disease, cerebrovascular disease or peripheral arterial disease.</p>§<p>Fever, anorexia, and weight loss.</p><p>ANA = antinuclear antibodies; ESR = erythrocyte sedimentation rate; CRP = C-reactive protein.</p